Groprinosin vs Icotrokinra

Overview

Groprinosin and Icotrokinra are both immune support peptides, but they differ in mechanism, dosing, and regulatory status.

This page compares Groprinosin and Icotrokinra across their primary use, typical dosing, reported benefits and side effects, and U.S. regulatory status. For the full monograph on either compound — mechanism of action, clinical research, and references — follow the article links.

Side-by-side comparison

Key differences

Primary use. Groprinosin is categorised under Immune Support, while Icotrokinra falls under Immune Support. Because they target a similar goal, they are common alternatives to weigh against each other.

Regulatory status. Groprinosin: not FDA-approved; treated as a research compound. Icotrokinra: FDA-approved.

Dosing. Groprinosin is typically dosed at 500-1000 mg (three times daily). Typical dosing for Icotrokinra is not catalogued.

Can you stack them?

Some protocols combine peptides, but stacking Groprinosin and Icotrokinra has not been validated for safety or efficacy in controlled trials. Combining compounds can change their effects and risks. Nothing here is medical advice — consult a qualified healthcare provider before starting or combining any protocol.

Frequently asked questions

What is the difference between Groprinosin and Icotrokinra?

Groprinosin and Icotrokinra are both immune support peptides, but they differ in mechanism, dosing, and regulatory status. Groprinosin is not FDA-approved; generally classified as a research compound, whereas Icotrokinra is FDA-approved for one or more indications.

What is Groprinosin used for?

Antiviral immune booster.

What is Icotrokinra used for?

Oral macrocyclic peptide. First-in-class IL-23 receptor antagonist. FDA approved March 17, 2026 for plaque psoriasis.

Can you take Groprinosin and Icotrokinra together?

Some users combine peptides within a single protocol, but stacking Groprinosin and Icotrokinra has not been established as safe or effective in controlled trials. Neither this comparison nor PeptideSciences101 is medical advice — consult a qualified healthcare provider before combining any compounds.

Is Groprinosin or Icotrokinra FDA-approved?

Groprinosin is not FDA-approved; generally classified as a research compound. Icotrokinra is FDA-approved for one or more indications.